|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation | |||||
| Amortization | |||||
| Accretion on purchased loans | |||||
| Compensation expense on employee and director stock purchases, stock options, and restricted stock units | |||||
| Net losses on sales of securities | |||||
| Net change in market value of equity securities | |||||
| Gains on sales of loans and capitalized servicing rights | |||||
| Loans originated for sale | |||||
| Proceeds from loan sales | |||||
| Earnings on bank-owned life insurance | |||||
| Proceeds from bank owned life insurance policy | |||||
| Earnings on death benefit from bank-owned life insurance | |||||
| (Gains) on sales of other real estate owned | |||||
| Proceeds from sales of other real estate owned | |||||
| Write downs of other real estate owned | |||||
| Deferred federal income tax (expense) benefit | |||||
| Net change in: | |||||
| Other assets | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Sales of securities available for sale | |||||
| Sales of equity securities | |||||
| Proceeds from Federal Home Loan Bank stock redemption | |||||
| Maturities, prepayments and calls of securities available for sale | |||||
| Maturities, prepayments and calls of securities held to maturity | |||||
| Purchases of securities available for sale | |||||
| Purchases of securities held to maturity | |||||
| Purchases of equity securities | |||||
| Purchases of Federal Home Loan Bank stock | |||||
| Purchase of bank-owned life insurance policies | |||||
| Purchase of Federal Reserve Bank stock | |||||
| Loan originations and payments, net | |||||
| Proceeds from sales of other real estate owned | |||||
| Proceeds from bank owned life insurance death benefits claim | |||||
| Additions to premises and equipment | |||||
| Proceeds from (payments for) derivative contracts, net | |||||
| Payments from (payments for) derivative contracts | |||||
| Issuance costs from Merger | |||||
| Cash received from merger with Fentura Financial, Inc. | |||||
| Net cash (used in)/provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Net change in deposits | |||||
| Net change in short term borrowings | |||||
| Proceeds from borrowings | |||||
| Payments on borrowings | |||||
| Issuance of common stock | |||||
| Repurchase of common stock | |||||
| Share based compensation withholding obligation | |||||
| Cash dividends | |||||
| Cash proceeds from common stock offering | |||||
| Net cash provided by/(used in) financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Beginning cash and cash equivalents | |||||
| Ending cash and cash equivalents | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for federal income taxes | |||||
| Noncash Transactions | |||||
| Loans transferred to other real estate owned | |||||
| Acquisition of assets from merger, net of cash | |||||
| Acquisition of liabilities from merger | |||||
| Issuance of common stock as consideration for merger | |||||
Loading...